This includes targeting CDK7 in order to prevent RNAPII phosphorylation and subsequent transcription initiation, with the CDK7 inhibitor THZ1 having been shown to suppress tumour growth in orthotopic DMG orthotopic [74]. Here, CDK7 is linked to neoplasm.